Only one (2.1%) patient developed hepatotoxicity after 6 months of INH therapy, with ALT elevation over 3x the reference values and abdominal pain, while treating CMV infection with intravenous ganciclovir - INH was suspended and abnormalities resolved. This evidence concerns the gene GPT and hepatotoxicity.